Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

Benralizumab is the first treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. The drug, which is delivered by an injection, helps to treat flare-ups of the ...